| Sorafenib | IC50 | 6.2 [1] |
| Sorafenib | Ki | 6.0 [1] |
| 3-[(3,5-Dibromo-4-hydroxyphenyl)methylidene]-5-iodo-1,2-dihydroindol-2-ol | IC50 | 9.0 [1] |
| Vemurafenib | IC50 | 48.0 [1], 128.0 [2], 135.0 [3], 410.0 [4], 10000.0 [5] |
| 3-(Dimethylamino)-N-(3-(4-hydroxybenzamido)-4-methylphenyl)benzamide | IC50 | 31.0 [1], 70.0 [2], 17000.0 [3] |
| Staurosporine | IC50 | 130.0 [1], 140.0 [2], 240.0 [3], 10000.0 [4] |
| 4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 330.0 [1], 370.0 [2], 2000.0 [3] |
| CID 46209401 | IC50 | 1.4 [1], 1.5 [2], 5.0 [3], 62.0 [4] |
| Doramapimod | IC50 | 1000.0 [1], 1400.0 [2] |
| Methyl 5-tert-butyl-3-(3-phenylureido)thiophene-2-carboxylate | IC50 | 17000.0 [1] |
| Methyl 5-tert-butyl-3-(3-(4-hydroxyphenyl)ureido)thiophene-2-carboxylate | IC50 | 15000.0 [1], 18000.0 [2] |
| 1-(5-Tert-butyl-1,2-oxazol-3-YL)-3-(4-pyridin-4-yloxyphenyl)urea | IC50 | 230.0 [1] |
| 5-Tert-Butyl-3-(3-p-tolyl-ureido)-thiophene-2-carboxylic acid methyl ester | IC50 | 1700.0 [1] |
| 1-(5-Tert-butyl-2-(dimethylcarbamoyl)thiophen-3-yl)-3-p-tolylurea | IC50 | 15000.0 [1] |
| 1-(5-Tert-butylisoxazol-3-yl)-3-(4-phenoxyphenyl)urea | IC50 | 540.0 [1], 1100.0 [2] |
| Methyl 5-tert-butyl-3-(3-(5-tert-butyl-1,3,4-thiadiazol-2-yl)ureido)thiophene-2-carboxylate | IC50 | 11000.0 [1] |
| 4-(4-(3-(4-Bromo-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide | IC50 | 6.0 [1] |
| 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]cyclohexyl]oxy-N-methylpyridine-2-carboxamide | IC50 | 75.0 [1], 1500.0 [2] |
| N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide | IC50 | 6.5 [1] |
| N-(3-(5-Chloro-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide | Ki | 3.3 [1] |
| Cyclohexanol, 4-(4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl)-, trans- | IC50 | 50.0 [1], 50000.0 [2] |
| Raf265(chir-265) | IC50 | 19.0 [1], 1200.0 [2] |
| t-TUCB | IC50 | 10000.0 [1] |
| (NE)-N-[5-[2-[4-[2-(dimethylamino)ethoxy]phenyl]-5-pyridin-4-yl-1H-imidazol-4-yl]-2,3-dihydroinden-1-ylidene]hydroxylamine | Ki | 1.72 [1] |
| LY-3009120 | IC50 | 4.3 [1], 42.0 [2] |
| 3-[2-Phenyl-4-(Pyridin-4-Yl)-1h-Imidazol-5-Yl]phenol | IC50 | 23.0 [1] |
| 4-[3-Methyl-2-piperidin-4-yl-5-[3-(trifluoromethyl)phenyl]imidazol-4-yl]-N-[(1S)-1-phenylethyl]pyridin-2-amine | IC50 | 810.0 [1] |
| Methyl 3-(3-(4-aminophenyl)ureido)-5-tert-butylthiophene-2-carboxylate | IC50 | 18000.0 [1] |
| N-Methyl-4-{[trans-4-({[4-(trifluoromethoxy)phenyl]carbamoyl}amino)cyclohexyl]oxy}benzamide | IC50 | 10000.0 [1] |
| Methyl 5-isopropyl-3-(3-p-tolylureido)thiophene-2-carboxylate | IC50 | 4000.0 [1] |
| 5-Tert-Butyl-3-(3-p-tolyl-ureido)-1H-pyrrole-2-carboxylic acid methyl ester | IC50 | 3000.0 [1] |
| 1-(5-Tert-butyl-2-(methylcarbamoyl)thiophen-3-yl)-3-p-tolylurea | IC50 | 4900.0 [1] |
| Methyl 5-tert-butyl-3-(3-p-tolylureido)furan-2-carboxylate | IC50 | 3000.0 [1] |
| 4-(4-(3-(2-Methoxy-5-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide | IC50 | 53.0 [1] |
| 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-(2-morpholin-4-ylethyl)pyridine-2-carboxamide | IC50 | 73.0 [1] |
| 5-{4-[3-(2-Methoxy-5-trifluoromethyl-phenyl)-ureido]-phenoxy}-N-methyl-nicotinamide | IC50 | 61.0 [1] |
| 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-ethylpicolinamide | IC50 | 26.0 [1] |
| Methyl 5-tert-butyl-3-(3-m-tolylureido)thiophene-2-carboxylate | IC50 | 20000.0 [1] |
| Methyl 5-tert-butyl-3-(3-(3,4-dichlorophenyl)ureido)-1H-pyrrole-2-carboxylate | IC50 | 12000.0 [1] |
| 1-(4-Bromo-3-(trifluoromethyl)phenyl)-3-(4-(2-(dimethylcarbamoyl)pyridin-4-yloxy)phenyl)urea | IC50 | 170.0 [1] |
| 2-Phenyl-4-[3-(trifluoromethyl)phenyl]-5-(4-pyridyl)-1H-imidazole | IC50 | 2600.0 [1] |
| 2-Phenyl-4-(3-chlorophenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 90.0 [1] |
| 4-(2,4-Diphenyl-1H-imidazol-5-yl)-N-methylpyrimidin-2-amine | IC50 | 2100.0 [1] |
| 2-Phenyl-4-(2-chlorophenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 610.0 [1] |
| 2-Phenyl-4-(4-chlorophenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 56.0 [1] |
| 2-Phenyl-4-(4-methoxyphenyl)-5-(4-pyridyl)-1H-imidazole | IC50 | 950.0 [1] |
| 3-(3,5-Dibromo-4-hydroxybenzylidene)indolin-2-one | IC50 | 1300.0 [1] |
| 1-(2-(Aminomethyl)-5-tert-butylthiophen-3-yl)-3-p-tolylurea | IC50 | 13000.0 [1] |
| [4-Methyl-3-[[3-(methylsulfamoylamino)phenyl]methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate | IC50 | 300.0 [1] |
| [6-Chloro-4-methyl-3-[[3-(methylsulfamoylamino)phenyl]methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate | IC50 | 8.0 [1] |
| 3-[[2-Fluoro-3-(methylsulfamoylamino)phenyl]methyl]-4-methyl-7-pyrimidin-2-yloxychromen-2-one | IC50 | 23.0 [1] |
| 3-(3,5-Dichloro-4-hydroxybenzylidene)-5-phenylindolin-2-one | IC50 | 32.0 [1] |
| 3-(3,5-Dibromo-4-hydroxybenzylidene)-5-(cyclopropanecarbonyl)indolin-2-one | IC50 | 25.0 [1] |
| Methyl 5-tert-butyl-3-(3-(1-isopropyl-1H-pyrazol-3-yl)ureido)thiophene-2-carboxylate | IC50 | 16000.0 [1] |
| Methyl 5-tert-butyl-3-(3-(3-chlorophenyl)ureido)thiophene-2-carboxylate | IC50 | 22000.0 [1] |
| Methyl 5-tert-butyl-3-(3-(3,4-dichlorophenyl)ureido)thiophene-2-carboxylate | IC50 | 20000.0 [1] |
| 3-(4-(3-(5-Tert-butylisoxazol-3-yl)ureido)phenoxy)-N-methylbenzamide | IC50 | 120.0 [1] |
| 5-(4-Hydroxy-2,6-dimethylstyryl)nicotinic acid | IC50 | 398.0 [1], 400.0 [2] |
| 4-(4-(3-(5-Tert-butylisoxazol-3-yl)ureido)phenoxy)benzoic acid | IC50 | 4400.0 [1], 6300.0 [2] |
| 3-(2-Aminopropan-2-yl)-N-[(2R)-7-[(7-oxo-6,8-dihydro-5H-1,8-naphthyridin-4-yl)oxy]-1,2,3,4-tetrahydronaphthalen-2-yl]-5-(trifluoromethyl)benzamide | IC50 | 2.5 [1], 60.0 [2] |
| N-[5-Amino-1-[(4-methoxyphenyl)methyl]pyrazol-4-yl]-5-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-2-methylbenzamide | IC50 | 2.87 [1], 107.1 [2] |
| 3-[(3,5-Dichloro-4-hydroxyphenyl)methylidene]-5-(furan-2-carbonyl)-1H-indol-2-one | IC50 | 46.0 [1] |
| 6,6-Dimethyl-8-[1-(oxetan-3-yl)piperidin-4-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile | IC50 | 50000.0 [1] |
| [4,6-Dimethyl-3-[[3-(methylsulfamoylamino)phenyl]methyl]-2-oxochromen-7-yl] N,N-dimethylcarbamate | IC50 | 78.0 [1] |
| 5-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]cyclohexyl]oxy-N-methylpyridine-2-carboxamide | IC50 | 175.0 [1] |
| 4-[4-(1-Adamantylcarbamoylamino)cyclohexyl]oxy-N-methylbenzamide | IC50 | 10000.0 [1] |
| Methyl 5-tert-butyl-3-(3-(1-methyl-1H-pyrazol-3-yl)ureido)thiophene-2-carboxylate | IC50 | 6700.0 [1] |
| Methyl 5-tert-butyl-3-(3-(5-methyl-1,3,4-thiadiazol-2-yl)ureido)thiophene-2-carboxylate | IC50 | 1200.0 [1] |
| Methyl 5-tert-butyl-3-(3-(5-ethyl-1,3,4-thiadiazol-2-yl)ureido)thiophene-2-carboxylate | IC50 | 2000.0 [1] |
| 5-Bromomethyl-3-(3-p-tolyl-ureido)-thiophene-2-carboxylic acid methyl ester | IC50 | 6000.0 [1] |
| 3-[3-(1-Ethyl-3-pyrrolyl)ureido]-5-tert-butylthiophene-2-carboxylic acid methyl ester | IC50 | 7600.0 [1] |
| Methyl 5-tert-butyl-3-(3-(1-ethyl-1H-pyrazol-3-yl)ureido)thiophene-2-carboxylate | IC50 | 8000.0 [1] |
| Methyl 5-tert-butyl-3-(3-(1-isopropyl-1H-pyrrol-3-yl)ureido)thiophene-2-carboxylate | IC50 | 8100.0 [1] |
| 4-[3-[3-[4-Chloro-3-(trifluoromethyl)anilino]-3-oxopropyl]phenoxy]-N-methylpyridine-2-carboxamide | IC50 | 9.0 [1], 25000.0 [2] |
| 4-[[7-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]-N-methylpyridine-2-carboxamide | IC50 | 28.0 [1], 2900.0 [2] |
| 4-[[7-[[4-(Aminomethyl)-3-(trifluoromethyl)phenyl]carbamoyl]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]-N-methylpyridine-2-carboxamide | IC50 | 16.0 [1], 5000.0 [2] |
| 4-[[7-[[3-(Aminomethyl)-5-(trifluoromethyl)phenyl]carbamoyl]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]-N-methylpyridine-2-carboxamide | IC50 | 11.0 [1], 1400.0 [2] |
| 3-[(Dimethylamino)methyl]-N-[(2R)-7-[(7-oxo-6,8-dihydro-5H-1,8-naphthyridin-4-yl)oxy]-1,2,3,4-tetrahydronaphthalen-2-yl]-5-(trifluoromethyl)benzamide | IC50 | 2.2 [1], 50.0 [2] |
| 4-[4-[3-[4-Chloro-3-(trifluoromethyl)anilino]-3-oxopropyl]phenoxy]-N-methylpyridine-2-carboxamide | IC50 | 10.0 [1], 25000.0 [2] |
| N-[3-(Aminomethyl)-5-(trifluoromethyl)phenyl]-7-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-1,2,3,4-tetrahydronaphthalene-2-carboxamide | IC50 | 6.2 [1], 150.0 [2] |
| (2S)-N-[3-(Aminomethyl)-5-(trifluoromethyl)phenyl]-7-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-1,2,3,4-tetrahydronaphthalene-2-carboxamide | IC50 | 4.5 [1], 130.0 [2] |
| (2R)-N-[3-(Aminomethyl)-5-(trifluoromethyl)phenyl]-7-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-1,2,3,4-tetrahydronaphthalene-2-carboxamide | IC50 | 6.0 [1], 780.0 [2] |
| (2S)-7-[2-(Cyclopropanecarbonylamino)pyridin-4-yl]oxy-N-[3-[(dimethylamino)methyl]-5-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydronaphthalene-2-carboxamide | IC50 | 3.3 [1], 130.0 [2] |
| 7-[2-(Cyclopropanecarbonylamino)pyridin-4-yl]oxy-N-[3-[(propan-2-ylamino)methyl]-5-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydronaphthalene-2-carboxamide | IC50 | 4.6 [1], 190.0 [2] |
| (2S)-7-(2-Acetamidopyridin-4-yl)oxy-N-[3-(aminomethyl)-5-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydronaphthalene-2-carboxamide | IC50 | 6.0 [1], 150.0 [2] |
| trans-4-{4-[3-(4-Chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-benzoic acid | IC50 | 4300.0 [1] |
| N-Methyl-4-[4-[[4-(trifluoromethoxy)phenyl]carbamoylamino]cyclohexyl]oxypyridine-2-carboxamide | IC50 | 10000.0 [1] |
| 4-[4-(1-Adamantylcarbamoylamino)phenoxy]-N-methylpyridine-2-carboxamide | IC50 | 1000.0 [1], 10000.0 [2] |
| N-Methyl-4-[4-[[4-(trifluoromethoxy)phenyl]carbamoylamino]phenoxy]pyridine-2-carboxamide | IC50 | 30.0 [1] |
| N-[4-Methyl-3-(6-morpholin-4-ylpyrimidin-4-yl)phenyl]-3-(trifluoromethyl)benzamide | IC50 | 0.14 [1] |
| N-[4-Methyl-3-(2-morpholin-4-yl-6-prop-1-en-2-ylpyrimidin-4-yl)phenyl]-3-(trifluoromethyl)benzamide | IC50 | 0.09 [1], 0.14 [2] |
| N-[4-Methyl-3-(4-morpholin-4-yl-6-prop-1-en-2-ylpyrimidin-2-yl)phenyl]-3-(trifluoromethyl)benzamide | IC50 | 0.38 [1], 0.39 [2] |
| N-[4-Methyl-3-(4-morpholin-4-yl-6-propan-2-ylpyrimidin-2-yl)phenyl]-3-(trifluoromethyl)benzamide | IC50 | 0.64 [1], 0.71 [2] |
| N-[4-Methyl-3-(2-morpholin-4-yl-6-propan-2-ylpyrimidin-4-yl)phenyl]-3-(trifluoromethyl)benzamide | IC50 | 1.02 [1], 1.39 [2] |
| 4-Methyl-3-(2-morpholin-4-ylpyridin-4-yl)-N-[3-(trifluoromethyl)phenyl]benzamide | IC50 | 0.44 [1], 0.51 [2] |
| 2-(2-Cyanopropan-2-yl)-N-[4-methyl-3-(6-morpholin-4-ylpyrimidin-4-yl)phenyl]pyridine-4-carboxamide | IC50 | 1.42 [1], 2.95 [2] |
| 3-[6-(1,1-Dioxo-1,4-thiazinan-4-yl)-2-morpholin-4-ylpyrimidin-4-yl]-4-methyl-N-[3-(trifluoromethyl)phenyl]benzamide | IC50 | 1.11 [1], 1.18 [2] |
| N-[3-[2-(1,1-Dioxo-1,4-thiazinan-4-yl)-6-morpholin-4-ylpyrimidin-4-yl]-4-methylphenyl]-3-(trifluoromethyl)benzamide | IC50 | 0.9 [1], 0.95 [2] |
| N-[3-(2,6-Dimorpholin-4-ylpyrimidin-4-yl)-4-methylphenyl]-3-(trifluoromethyl)benzamide | IC50 | 0.1 [1], 0.12 [2] |
| 3-(2,6-Dimorpholin-4-ylpyrimidin-4-yl)-4-methyl-N-[3-(trifluoromethyl)phenyl]benzamide | IC50 | 0.54 [1], 0.58 [2] |